We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AXGN market cap is 283.87M. The company's latest EPS is USD -0.5026 and P/E is -87.35.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 36.96M | 36.16M | 36.66M | 38.16M | 41.27M |
Operating Income | -4.86M | -5.61M | -7.34M | -6.9M | -4.02M |
Net Income | -4.32M | -5.42M | -7.07M | -6.66M | -4.09M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 106.71M | 112.3M | 127.36M | 138.58M | 159.01M |
Operating Income | -31.41M | -23.18M | -25.42M | -29.71M | -21.46M |
Net Income | -29.14M | -23.79M | -26.99M | -28.95M | -21.72M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 195.52M | 195.39M | 189.47M | 191.64M | 194.63M |
Total Liabilities | 94.08M | 94.39M | 91.96M | 94.49M | 96.82M |
Total Equity | 101.45M | 101M | 97.51M | 97.15M | 97.81M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 154.64M | 201.38M | 208.02M | 195.39M | 196.83M |
Total Liabilities | 22.49M | 78.23M | 95.47M | 94.39M | 101.16M |
Total Equity | 132.15M | 123.15M | 112.55M | 101M | 95.67M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -17.43M | -16.07M | -7.42M | -7.13M | -5.51M |
Investing | -1.99M | -3.2M | -786k | 13.54M | 19.53M |
Financing | 981k | 1.79M | 633k | 1.53M | 1.54M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -19.87M | -9.63M | -13.54M | -16.07M | -5.72M |
Investing | 27.27M | -16.96M | -23.65M | -3.2M | 19.25M |
Financing | 4.03M | 40.47M | 20.45M | 1.79M | 1.95M |
Market Cap | 283.87M |
Price to Earnings Ratio | -87.35 |
Price to Sales Ratio | 11.93 |
Price to Cash Ratio | 61.14 |
Price to Book Ratio | 19.83 |
Dividend Yield | - |
Shares Outstanding | 43.21M |
Average Volume (1 week) | 253.65k |
Average Volume (1 Month) | 327.98k |
52 Week Change | -29.96% |
52 Week High | 10.8324 |
52 Week Low | 3.45 |
Spread (Intraday) | 0.03 (0.46%) |
Company Name | Axogen Inc |
Address |
1010 dale st. no st paul, minnesota 55117 5603 |
Website | https://www.axogeninc.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions